Patent details

Basic Information

Publication number:

EP1931306

PCT Application Number:

US2006038913

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP068162833

PCT Publication Number:

WO2007041664

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

NON-PROTEIN STABILIZED CLOSTRIDIAL TOXIN PHARMACEUTICAL COMPOSITIONS

French Title of Invention:

PRÉPARATIONS PHARMACEUTIQUES DE TOXINE CLOSTRIDIALE NON STABILISÉES PAR UNE PROTÉINE

German Title of Invention:

PROTEINFREIE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT STABILISIERTEM CLOSTRIDIENTOXIN

SPC Number:

Dates

Filing date:

04/10/2006

Grant date:

31/07/2013

EP Publication Date:

18/06/2008

PCT Publication Date:

12/04/2007

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

18/06/2008

EP B1 Publication Date:

31/07/2013

EP B2 Publication Date:

22/09/2021

EP B3 Publication Date:

Lapsed date:

04/10/2013

Expiration date:

04/10/2026

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

15/09/2021

 

 

Name:

ALLERGAN, INC.

Address:

2525 Dupont Drive, Irvine, CA 92612, United States (US)

Inventor

Name:

HUNT, Terrence, J.

Address:

United States (US)

Priority

1

Priority Number:

725126 P

Priority Date:

06/10/2005

Priority Country:

United States (US)

2

Priority Number:

524683

Priority Date:

21/09/2006

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/00; A61K 47/10; A61K 47/26; A61K 47/32; A61K 38/48;

Publication

European Patent Bulletin

Issue number:

202138

Publication date:

22/09/2021

Description:

Patent maintained (B2 publication)

Filing date	Document type	Number of pages